Kidney Cancer, Version 2.2017: Clinical practice guidelines in oncology

Robert J. Motzer; Eric Jonasch; Neeraj Agarwal; Sam Bhayani; William P. Bro; Sam S. Chang; Toni K. Choueiri; Brian A. Costello; Ithaar H. Derweesh; Mayer Fishman; Thomas H. Gallagher; John L. Gore; Steven L. Hancock; Michael R. Harrison; Won Kim; Christos Kyriakopoulos; Chad Lagrange; Elaine T. Lam; Clayton Lau; M. Dror Michaelson; Thomas Olencki; Phillip M. Pierorazio; Elizabeth R. Plimack

doi:10.6004/jnccn.2017.0100

Kidney Cancer, Version 2.2017: Clinical practice guidelines in oncology

Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Sam Bhayani, William P. Bro, Sam S. Chang, Toni K. Choueiri, Brian A. Costello, Ithaar H. Derweesh, Mayer Fishman, Thomas H. Gallagher, John L. Gore, Steven L. Hancock, Michael R. Harrison, Won Kim, Christos Kyriakopoulos, Chad Lagrange, Elaine T. Lam, Clayton Lau, M. Dror MichaelsonThomas Olencki, Phillip M. Pierorazio, Elizabeth R. Plimack

Oncology

Research output: Contribution to journal › Review article › peer-review

274 Scopus citations

Abstract

The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal carcinoma. These guidelines are developed by a multidisciplinary panel of leading experts from NCCN Member Institutions consisting of medical oncologists, hematologists and hematologic oncologists, radiation oncologists, urologists, and pathologists. The NCCN Guidelines are in continuous evolution and are updated annually or sometimes more often, if new high-quality clinical data become available in the interim.

Original language	English (US)
Pages (from-to)	804-834
Number of pages	31
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	15
Issue number	6
DOIs	https://doi.org/10.6004/jnccn.2017.0100
State	Published - Jun 1 2017

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2017.0100

Cite this

Motzer, R. J., Jonasch, E., Agarwal, N., Bhayani, S., Bro, W. P., Chang, S. S., Choueiri, T. K., Costello, B. A., Derweesh, I. H., Fishman, M., Gallagher, T. H., Gore, J. L., Hancock, S. L., Harrison, M. R., Kim, W., Kyriakopoulos, C., Lagrange, C., Lam, E. T., Lau, C., ... Plimack, E. R. (2017). Kidney Cancer, Version 2.2017: Clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network, 15(6), 804-834. https://doi.org/10.6004/jnccn.2017.0100

Motzer, RJ, Jonasch, E, Agarwal, N, Bhayani, S, Bro, WP, Chang, SS, Choueiri, TK, Costello, BA, Derweesh, IH, Fishman, M, Gallagher, TH, Gore, JL, Hancock, SL, Harrison, MR, Kim, W, Kyriakopoulos, C, Lagrange, C, Lam, ET, Lau, C, Dror Michaelson, M, Olencki, T, Pierorazio, PM & Plimack, ER 2017, 'Kidney Cancer, Version 2.2017: Clinical practice guidelines in oncology', JNCCN Journal of the National Comprehensive Cancer Network, vol. 15, no. 6, pp. 804-834. https://doi.org/10.6004/jnccn.2017.0100

@article{63100148371848fc90c2e5a9ec7fc103,

title = "Kidney Cancer, Version 2.2017: Clinical practice guidelines in oncology",

abstract = "The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal carcinoma. These guidelines are developed by a multidisciplinary panel of leading experts from NCCN Member Institutions consisting of medical oncologists, hematologists and hematologic oncologists, radiation oncologists, urologists, and pathologists. The NCCN Guidelines are in continuous evolution and are updated annually or sometimes more often, if new high-quality clinical data become available in the interim.",

author = "Motzer, {Robert J.} and Eric Jonasch and Neeraj Agarwal and Sam Bhayani and Bro, {William P.} and Chang, {Sam S.} and Choueiri, {Toni K.} and Costello, {Brian A.} and Derweesh, {Ithaar H.} and Mayer Fishman and Gallagher, {Thomas H.} and Gore, {John L.} and Hancock, {Steven L.} and Harrison, {Michael R.} and Won Kim and Christos Kyriakopoulos and Chad Lagrange and Lam, {Elaine T.} and Clayton Lau and {Dror Michaelson}, M. and Thomas Olencki and Pierorazio, {Phillip M.} and Plimack, {Elizabeth R.}",

note = "Publisher Copyright: {\textcopyright} JNCCN-Journal of the National Comprehensive Cancer Network.",

year = "2017",

month = jun,

day = "1",

doi = "10.6004/jnccn.2017.0100",

language = "English (US)",

volume = "15",

pages = "804--834",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "6",

}

TY - JOUR

T1 - Kidney Cancer, Version 2.2017

T2 - Clinical practice guidelines in oncology

AU - Motzer, Robert J.

AU - Jonasch, Eric

AU - Agarwal, Neeraj

AU - Bhayani, Sam

AU - Bro, William P.

AU - Chang, Sam S.

AU - Choueiri, Toni K.

AU - Costello, Brian A.

AU - Derweesh, Ithaar H.

AU - Fishman, Mayer

AU - Gallagher, Thomas H.

AU - Gore, John L.

AU - Hancock, Steven L.

AU - Harrison, Michael R.

AU - Kim, Won

AU - Kyriakopoulos, Christos

AU - Lagrange, Chad

AU - Lam, Elaine T.

AU - Lau, Clayton

AU - Dror Michaelson, M.

AU - Olencki, Thomas

AU - Pierorazio, Phillip M.

AU - Plimack, Elizabeth R.

PY - 2017/6/1

Y1 - 2017/6/1

N2 - The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal carcinoma. These guidelines are developed by a multidisciplinary panel of leading experts from NCCN Member Institutions consisting of medical oncologists, hematologists and hematologic oncologists, radiation oncologists, urologists, and pathologists. The NCCN Guidelines are in continuous evolution and are updated annually or sometimes more often, if new high-quality clinical data become available in the interim.

AB - The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal carcinoma. These guidelines are developed by a multidisciplinary panel of leading experts from NCCN Member Institutions consisting of medical oncologists, hematologists and hematologic oncologists, radiation oncologists, urologists, and pathologists. The NCCN Guidelines are in continuous evolution and are updated annually or sometimes more often, if new high-quality clinical data become available in the interim.

UR - http://www.scopus.com/inward/record.url?scp=85020412401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020412401&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2017.0100

DO - 10.6004/jnccn.2017.0100

M3 - Review article

C2 - 28596261

AN - SCOPUS:85020412401

SN - 1540-1405

VL - 15

SP - 804

EP - 834

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 6

ER -

Kidney Cancer, Version 2.2017: Clinical practice guidelines in oncology

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this